细胞癌:在向治疗时代的预后
Kathrin Halfter1, Michael Staehler2, Dieter Hölzel1
1Institute of Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Marchioninistraße 15, 81377 Munich, Germany.
Current oncology (Toronto, Ont.)
|September 26, 2025
概括
早期检测和新的治疗方法改善了细胞癌 (RCC) 的存活率,特别是在高风险患者中. 需要进一步努力,以更早地诊断转移性RCC (mRCC),以获得更好的外科治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 公共卫生 公共卫生
背景情况:
- 最近在细胞癌 (RCC) 治疗和诊断成像方面取得了进展.
- 这些变化对患者特征和预后的影响需要评估.
研究的目的:
- 分析20多年来细胞癌 (RCC) 患者特征和生存率的趋势.
- 评估新药疗法和改进的成像对RCC预后的影响.
主要方法:
- 一项观察性研究分析了2000年至2019年在德国诊断的210,418例RCC病例.
- 病例按诊断时期 (2000-2005,2006-2014,2015-2019) 分组,反映了治疗时期.
- 分析了五年相对存活率 (RS) 的趋势,使用Poisson回归来分析不同风险组和转移性RCC (mRCC).
主要成果:
- 患者在诊断时的年龄增加,低风险疾病的增加和mRCC的减少.
- 在所有风险组和mRCC中,五年RS有所改善.
- 低风险和高风险RCC的预后明显改善,高风险ccRCC患者从新的药物治疗中受益.
结论:
- 早期检测已经改善了大多数RCC患者的预后.
- 进一步的研究应侧重于早期诊断mRCC,以便及时进行手术干预.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
34.1K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
